Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

doi:10.3748/wjg.v12.i10.1536

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5393)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

547

HTML

3936

Figures (1-5)

478

Tables (1-2)

432

Sum=5393

Mar 14, 2006 (publication date) through Nov 1, 2025

Times Cited of This Article

Times Cited (115)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Colorectal Cancer

World J Gastroenterol. Mar 14, 2006; 12(10): 1536-1544
Published online Mar 14, 2006. doi: 10.3748/wjg.v12.i10.1536

Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

Judith YMN Engwegen, Helgi H Helgason, Annemieke Cats, Nathan Harris, Johannes MG Bonfrer, Jan HM Schellens, Jos H Beijnen

Judith YMN Engwegen, Jos H Beijnen, Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands

Helgi H Helgason, Jan HM Schellens, Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Annemieke Cats, Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Nathan Harris, Ciphergen Biosystems Inc., Freemont, California, United States

Johannes MG Bonfrer, Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Jan HM Schellens, Jos H Beijnen, Utrecht University, Faculty of Pharmaceutical Sciences, Department of Biomedical analysis, Utrecht, The Netherlands

Author contributions: All authors contributed equally to the work.

Correspondence to: Judith YMN Engwegen, Slotervaart Hospital, Department of Pharmacy and Pharmacology, PO Box 90440, 1006 BK Amsterdam, The Netherlands. apjen@slz.nl

Telephone: +31-20-5125008 Fax: +31-20-5124753

Received: June 23, 2005
Revised: September 1, 2005
Accepted: October 9, 2005
Published online: March 14, 2006

Core Tip